News/ News/ Patients NICE expands cover for AZ’s high potassium drug Lokelma Phil Taylor AstraZeneca, HEOR, hyperkalaemia, Lokelma, NHS, NICE, patients 0 Comment NICE has recommended extending funding via the NHS for AstraZeneca’s elevated potassium therapy Lokelma in new guidance, making Share X NICE expands cover for AZ’s high potassium drug Lokelma https://pharmaphorum.com/news/nice-expands-cover-for-azs-high-potassium-drug-lokelma/
AstraZeneca, HEOR, hyperkalaemia, Lokelma, NHS, NICE, patients
0 Comment
